Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
14,014,675
-
Shares change
-
+152,157
-
Total reported value, excl. options
-
$32,148,839
-
Value change
-
-$634,604
-
Put/Call ratio
-
121%
-
Number of buys
-
34
-
Number of sells
-
-28
-
Price
-
$2.30
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2023
92 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q3 2023.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,014,675 shares
of 43,411,663 outstanding shares and own 32% of the company stock.
Largest 10 shareholders include Slate Path Capital LP (2,402,455 shares), BlackRock Inc. (2,128,950 shares), VANGUARD GROUP INC (2,124,906 shares), GEODE CAPITAL MANAGEMENT, LLC (762,421 shares), Bleichroeder LP (755,028 shares), STATE STREET CORP (698,195 shares), DIMENSIONAL FUND ADVISORS LP (566,613 shares), Robertson Stephens Wealth Management, LLC (478,500 shares), Monaco Asset Management SAM (359,739 shares), and SANDERS MORRIS HARRIS LLC (346,212 shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.